Ransom Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.39M Buy
11,540
+114
+1% +$22.5K 0.94% 27
2025
Q3
$2.12M Sell
11,426
-496
-4% -$85K 0.95% 25
2025
Q2
$1.82M Sell
11,922
-275
-2% -$42.3K 0.86% 30
2025
Q1
$2.02M Sell
12,197
-10
-0.1% -$1.56K 1% 24
2024
Q4
$1.77M Sell
12,207
-274
-2% -$42.5K 0.81% 29
2024
Q3
$2.02M Sell
12,481
-275
-2% -$43.8K 0.95% 25
2024
Q2
$1.86M Buy
12,756
+407
+3% +$60.5K 0.93% 24
2024
Q1
$1.95M Buy
+12,349
New +$1.97M 1.04% 23

Other funds holding JNJ

Ransom Advisory's JNJ Position: Q4 2025 in Review

Ransom Advisory increased its Johnson & Johnson (JNJ) stake by 1% in Q4 2025, buying an estimated $22.5K and bringing the position to 11,540 shares worth $2.39M. The position accounts for 0.94% of the portfolio, ranked #27.

Ransom Advisory first reported a position in JNJ in Q1 2024 and has held it in 8 quarters since. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Ransom Advisory held 11,540 shares of Johnson & Johnson worth $2.39M as of Q4 2025.
  • Ransom Advisory bought 114 Johnson & Johnson shares in Q4 2025, an estimated $22.5K.
  • Johnson & Johnson made up 0.94% of Ransom Advisory's portfolio in Q4 2025, its #27 holding.
  • Ransom Advisory first reported a position in Johnson & Johnson in Q1 2024 and has held it in 8 quarters since.
  • 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.